Skip to main content

Month: January 2024

Equinor to take full ownership in Empire Wind through a swap transaction with bp in the US

Equinor (OSE: EQNR, NYSE: EQNR) has entered into a swap transaction with bp, under which Equinor will take full ownership of the Empire Wind lease and projects and bp will take full ownership of the Beacon Wind lease and projects. Under the agreement, Equinor will take 100% ownership of Empire Offshore Wind Holdings LLC. Subject to certain conditions, Equinor will also take over bp’s 50% share of the South Brooklyn Marine Terminal (SBMT) lease. Bp will take over Beacon Wind Holdings LLC and the associated project company that holds the Astoria Gateway for Renewable Energy site and will become the operator of the Beacon Wind projects. The transaction will be cash neutral, except for standard settlements of cash and working capital items. The agreement provides Equinor and bp with the flexibility to pursue their respective priorities under...

Continue reading

Exco Technologies Limited 2023 Annual Meeting Results

TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) — Exco Technologies Limited (TSX-XTC) announced voting results from its 2023 annual meeting of shareholders held on January 24, 2024. A total of 25,764,482 Common Shares or 66.27% of our issued and outstanding Common Shares, were voted in connection with the meeting. Based on proxies received prior to the meeting, each director nominee was elected by a substantial majority as follows:  VotesFor VotesWithheld/AgainstEdward H. Kernaghan 95.2 % 4.8 %Darren M. Kirk 99.1 % 0.9 %Robert B. Magee 99.5 % 0.5 %Colleen M. McMorrow 99.5 % 0.5 %Brian A. Robbins 96.2 % 3.8 %         Full results of the votes are included as Appendix A to this press release. Exco Technologies Limited is a global supplier of innovative technologies servicing the die-cast, extrusion and automotive...

Continue reading

Dupixent® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE)

Approval based on Phase 3 EoE KIDS trial showing a greater proportion of children taking Dupixent achieved histological remission compared to placebo Expanded indication marks second disease for which Dupixent is approved in children this young, underscoring the commitment to bringing therapies to young patients with significant unmet needs   EoE is one of five FDA-approved indications for Dupixent in the U.S. for which type 2 inflammation is an underlying driver TARRYTOWN, N.Y. and PARIS, Jan. 25, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for the treatment of pediatric patients aged 1 to 11 years, weighing at least 15 kg, with eosinophilic esophagitis (EoE). Dupixent is now the first and only...

Continue reading

Record date for the transfer of warrants to existing shareholders is set to 2 February 2024

As announced on 12 January 2024, the board of directors of Terranet AB (“Terranet” or the “Company”) has resolved to transfer warrants of series TO8 without consideration to the Company’s existing shareholders. The record date for receiving the warrants of series TO8 has now been set to 2 February 2024. The exercise period for subscription of shares with the support of warrants of series TO8 runs from 18 November 2024 to 29 November 2024. As announced through a press release on 12 January 2024, the board of directors of Terranet has resolved on two directed issues of units, one of which is conditional upon approval by the extraordinary general meeting on 31 January 2024. In order to give existing shareholders in the Company the opportunity to compensate themselves to some extent for the dilution effect that...

Continue reading

Christian Dior: 2023 : New record year for Christian Dior group

2023: New record year for Christian Dior group . Revenue: €86.2 billion. Profit from recurring operations: €22.8 billion. Growth higher in the fourth quarter than in the third quarter. Major economic and social impact in France and around the world Paris, January 25th, 2024 Christian Dior group recorded revenue of €86.2 billion in 2023, equating to organic growth of 13% with respect to 2022. All business groups reported strong organic revenue growth, with the exception of Wines & Spirits, which was faced with a high basis of comparison and high inventory levels. Europe, Japan and the rest of Asia achieved double-digit organic growth. In the fourth quarter, organic revenue growth came to 10%. Profit from recurring operations stood at €22.8 billion for 2023, up 8%. The current operating margin remained stable with respect to 2022. Group...

Continue reading

Plata Wine Partners Expands Portfolio of Exclusive Retail Wine Brands

Acquisition of 14 brands from Purple Brands enhances collection of wines from premium California appellations Napa, CA, Jan. 25, 2024 (GLOBE NEWSWIRE) — Plata Wine Partners officially announced the purchase of Purple Brands’ portfolio of exclusive retail wines. The acquisition includes 14 brands, such as Donovan-Parke, Main & Geary, Athenaeum, and Shiloh Road, highlighting fruit from distinctive California growing regions. “Bringing these new brands into our fold pushes us closer to producing 500,000 cases of wine this year. These lines also beautifully complement our current collection of premium wines from California appellations, including sub-AVAs in Napa, Sonoma, Monterey, San Luis Obispo, and Santa Barbara counties,” said Scott Smith, President and CEO, Plata Wine Partners. “It’s an exciting time of growth and new opportunities.” Plata...

Continue reading

Airport Passenger Screening Systems Market Size Worth USD 5.69 Billion in 2032 | Emergen Research

Rising number of terrorist attacks globally is creating a high demand for implementation of passenger screening systems that can handle higher passenger volumes without compromising security which is a major factor driving the Airport Passenger Screening Systems market revenue growth. Vancouver, Jan. 25, 2024 (GLOBE NEWSWIRE) — The global airport passenger screening systems market size was USD 2.35 Billion in 2022 and is expected to register a revenue CAGR of 9.3% during the forecast period. Rising number of terrorist attacks globally is creating a high demand for implementation of passenger screening systems that can handle higher passenger volumes without compromising security which is a major factor driving the market revenue growth. As more people prefer to fly for business and vacations, airports are improving their security...

Continue reading

Renovaro Biosciences Announces Results of Special Meeting of Shareholders

LOS ANGELES, Jan. 25, 2024 (GLOBE NEWSWIRE) — Renovaro Biosciences Inc. (NASDAQ: RENB) (the “Company”), a biotechnology corporation focusing on cell, gene, and immunotherapy, announced today the results of the Company’s Special Meeting of Shareholders held at 12:00 pm ET on January 25, 2024. All of the matters put forward before the Company’s shareholders for consideration and approval, as set out in the Company’s definitive proxy statement dated January 3, 2024, were approved by the requisite number of votes cast at the meeting. For complete results on all matters voted on at the meeting, please consult the Company’s Form 8-K which will be filed on EDGAR at www.sec.gov/edgar. ABOUT THE COMPANYRenovaro has developed advanced cell, gene, and immunotherapy platforms designed to renew the body’s natural tumor-fighting...

Continue reading

Toll Brothers Announces Opening of Brookview Single-Family Home Community in Lake Stevens, Washington

Onsite model home grand opening event to be held on Saturday, January 27 from noon – 4pm PTBrookview by Toll BrothersBrookview by Toll Brothers is now open in Lake Stevens, Washington; a new model home and quick move-in homes are available for tours.Brookview by Toll Brothers“Brookview is a unique community that offers a variety of flexible living options and an array of personalization selections,” said Kelley Moldstad, Group President of Toll Brothers in Washington and Oregon.LAKE STEVENS, Wash., Jan. 25, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the grand opening of its new Brookview community in Lake Stevens, Washington. The new boutique community of 23 homes, which is now open for sale, offers a collection of 2- and 3-story home...

Continue reading

OHA is the Lead Left Arranger of Greenway Health’s Private Unitranche Financing

New York, New York, Jan. 25, 2024 (GLOBE NEWSWIRE) — Oak Hill Advisors (“OHA”) served as the Lead Left Arranger of a private unitranche financing for Greenway Health, a provider of electronic health record and practice management solutions to the U.S. ambulatory market. OHA committed to half of the $375 million term loan used to refinance the company’s maturing syndicated first lien debt. OHA’s industry-specialist investment team model positioned it to quickly and confidently diligence the opportunity, with its speed being a meaningful factor in closing the transaction. OHA is one of the earliest investors in software credit, having deployed over $30 billion in both liquid and private financings for over 130 portfolio companies since 2004, and maintains a distinctive understanding of healthcare information technology through its...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.